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Introduction: In the blood transfusion patients may be 
exposed or are stimulated to produce red cell antibodies that 
cause immediate and delayed transfusion reactions. Antibodies 
that agglutinate the red blood cells are called signifiers. Already 
insignificant antibodies that agglutinate red blood cells "in 
vitro", and which do not promote changes in the body can be 
sub-categorized into Rh and Kell system, MNSs, Lewis, Duffy 
and Kidd.  
Objectives: Identify the types of irregular antibodies.  
Materials and Methods: This study was conducted through a 
wide reading-based research papers published from 2000 to 2014 
available on the websites: Scielo - Scientific Electronic Library 
Online, LILLACS - Latin American and Caribbean Sciences 
WWII Health and PubMed - US National Librany of 
Medicine and BIREME - Regional Library of 
Medicine. Inclusion criteria were: articles published in 
Portuguese, English and Spanish and exclusion criteria: review 
articles that do not directly addressed the issue of irregular 
antibodies and blood transfusion.  
Results and Discussion: We identified 51 articles on alternate 
sites: 43 in Scielo, 2 in BIREME, 1 in LILLACS and 5 found in 
PubMed. Only 22 articles met the inclusion criteria proposed for 
the study and were distributed in several categories: descriptive, 
quantitative and qualitative research.  
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Introduction 
 
Patients who require transfusion of red blood cell (RBC) concentrates are 
exposed or produce irregular antibodies that cause reactions against one or more 
red blood cells. This is because erythrocyte antigens are structures that are 
located on the erythrocyte membrane and detected by alloantibodies. The 
incidence of irregular antibodies is related to RBC transfused without 
phenotyping, the importance of which is related to the ability of the antigen to 
induce and react to an immune response when the subject's immune system is 
compromised due to the advancement of the disease, which reduces the 
immunological components exposing the patient to erythrocyte sensitization 
(BORDIN, 2007). 
Blood transfusions are known to involve risks which include viral, bacterial, 
hemolytic antibody reactions, blood incompatibility, mild, moderate, and severe 
adverse reactions. Patients who undergo blood transfusions in cases of urgency 
and emergency are often transfused without performing the compatibility test at 
the written request or by signing the term of responsibility of the requesting 
physician. In the case of non-chronic and acute diseases, pre-transfusion tests are 
already performed to determine blood group A, B, O and Rh D factor upon 
medical request. The procedures performed to blood transfusions are the pre-
transfusion research and research irregular antibodies (RIA) that are performed 
in blood samples from patients prior to blood transfusions (ANDRADE MVM, et 
al. 2010). 
PAI is also performed in patients with chronic and non-chronic diseases, who 
have thalassemia, sickle cell anemia, neoplasms and in cases of urgency and 
emergency. The haemotherapic transfused these diseases should have the same 
antibodies of patients to prevent immediate reactions, and delayed sensitization 
by antibodies (ANDRADEa M.V.M, et al. 2010). 
There are several types of irregular antibodies in different forms. After the 
discovery of blood groups, A, B, O in 1900 by Karl Landsteiner, this one found 
several antigens and antibodies in the membranes of the erythrocytes. These 
antibodies were classified as significant when they agglutinated the red blood 
cells, reducing the survival of red blood cells; And insignificant when they 
agglutinated the red blood cells, but did not affect survival in the organism. 
Conclusion: Common antibodies are Rh and Kell system. 
Erythrocyte sensitizations occur to each unit of transfused red 
blood cells. Therefore, phenotyping and genotyping for Rh, Kell, 
Duffy, Kidd and MNSs antibodies to patients undergoing blood 
transfusion is recommended for safe and quality therapy. 
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These antibodies were named as Rh and Kell system, MNSs, Lewis, Duffy and 
Kidd; these are identified in serum or plasma from donors and in patients who 
undergo blood transfusion. This is because each of these antigens have biological 
functions that are capable of causing red cell reactions when in contact with 
human antigen causes immediate reactions, late or the sudden death of the 
patient (CASTILHO I., 2008). 
After the knowledge of the antibodies of the Rh and Kell system, MNSs, 
Lewis, Duffy and Kidd, they were enrolled in hemotherapy programs, thus 
preventing and mitigating the risk of erythrocytic reactions and sensitization in 
patients (MEDEIROS et al., 2010). 
Due to the importance of ABO and Rh factor mapping in blood donors and 
patients, blood donation of all blood donors and patients for the Rh, Kell, MNSs, 
Lewis, Duffy and Kidd systems has become mandatory; these patients were 
enrolled in hemotherapy programs, thus preventing and mitigating the risk of 
reactions and sensitization (MEDEIROS et al., 2010). 
The need for knowledge of the Rh and Kell system is of great clinical importance. 
The ABO system has the antigens of the Rh and Kell system on its surface 
membranes, these existing plasma antibodies related to the Rh and Kell systems 
that bind to the patient's red blood cells causing transfusional hemolytic 
reactions (PINHEIROS et al., 2013). 
All hemotherapy services must follow mandatory norms established by 
Brazilian Resolution N°. 153 of the National Sanitary Surveillance Agency 
(ANVISA), which determines technical procedures for the use of hemotherapy 
products, which are: collection, processing, testing, storage, transportation, 
quality control, and he human use of venous blood, umbilical cord, placenta and 
bone marrow; failure to comply with these rules shall be governed according to 
the penalties described in Law Nº. 6437 of August 20, 1977 (ANDRADEb M.V.M 
et al. 2014).  
 
 
Erythrocyte polymorphism 
 
Erythrocyte polymorphism is a feature of great importance for the 
categorization of individuals regarding the antigens present in the red blood cell 
membrane and also contributes to the currently seen causes of hemolytic 
transfusion reactions (HARMENING p. 119; 2006). 
Blood group antigens have a genetic characteristic due to the presence of 
proteins, glycoproteins or glycolipids in the plasma membrane of blood cells. 
Thus, blood groups are established according to the antibody currently observed 
on the surface of the erythrocyte membrane. It is important to note that not all 
polymorphisms are characteristic of a blood group (HARMENING p. 120-121; 
2006). 
With the discovery of the system of blood groups by Karl Landsteiner, to 
date this system is of great clinical importance due to the results obtained 
through experiments performed by the scientist in blood samples, observing 
agglutinations in some of these samples classifying the blood groups as (A, B and 
O) (HARMENING p. 119-121; 2006). 
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About the existence of approximately 250 different types of erythrocyte 
antigens, currently the most frequent antibodies of the blood groups are of the 
ABO system, which has antigens of the system Rh and Kell and the antibodies of 
the system Kidd, Duffy and MNSs. These antibodies and antigens can be 
identified in erythrocyte associations reacting together with other antibodies 
causing changes in the patient's immune response, which stand out as immediate 
and late reactions occurring in blood transfusions (HARMENING p. 120-121; 
2006). 
In addition to these antibodies, observed other antibodies that may cause 
transfusion reactions that are classified as anti-Dia (Diego) and anti-U. Anti-Dia 
is an unusual but clinically important antibody. It can cause newborn hemolytic 
disease (NHD) and heterologous transfusion reaction (HTR) (HIRTSCH et al. 
2004). Anti-U antibody is an alloantibody that is detected in black individuals 
and can cause NHD and hemolytic transfusion reactions (CHAMONE et al. 
2003). 
Erythrocyte antibodies have several biological functions, which may be 
structural, structural and transport, receptor and adhesion function, enzyme or 
complement elements. 
Through genetic studies correlated to these antigens, protocols were 
developed that migrated to technical regulation to identify the erythrocyte 
phenotypes by: genotyping, serological methods, antiglobulin test (AGT), blood 
compatibility and RIA (VIEIRA et al. 2009). The use of this regulation prevents 
health problems and increases the risk of erythrocyte sensitization. 
In 1964, the Brazilian Ministry of Health established mandatory standards 
and protocols for the implementation of activities in the hemotherapy service, 
regulating imports and exports of hemotherapy products, mandatory inclusion of 
care with blood donors and patients, records in the blood public and private 
bodies and the carrying out of serological tests (BRITO et al. 2014). 
Currently the technique of blood group genotyping for blood transfusions is 
being used with high-technology and lower-cost equipment for patient care, such 
as PCR (polymerase chain reaction) and PCR-RFLP (polymerase chain reaction-
restriction fragment length polymorphism). These technologies facilitate the 
identification of antibodies, as well as enable partial or total "donor" screening of 
blood donors and Rh negative patients. This technique guarantees the detection 
of antibodies up to two days after transfusions, preventing future secondary 
sensitization (VIEIRA et al., 2009). 
 
Significant antibodies 
 
Rh system 
The antigens of this system have a high complexity to the anti-D antibody 
which is considered the most immunogenic antibody. The main antigen of this 
system is D antigen due to its high degree of immunogenicity. D antigen is 
encoded by the RHD gene in Rh positive individuals, observed that in the 
absence of the gene, there will be no production of the respective antigen. 
Individuals who have it are classified as Rh positive, while Rh negative does not 
contain this antigen. In pre-transfusion searches these antigens may be associated 
with other antigens of the Rh system which are anti-D / -C and anti-E / -c. The 
sensitivity of these antigens is due to the fact that red blood cell concentrates 
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transfused without erythrocyte phenotypes cause primary or secondary 
immunological response in the patient (STINGHEN et al., 2011).  
COVAS et al., in 2007, mentioned that anti-D antibody visualization is due 
to maternal or paternal sensitization corresponding to blood incompatibility and 
also influenced by Rh factor. In the transfusion routine, Rh negative individuals 
who receive a transfusion of 200 mL of blood containing D antigen can be 
sensitized by that antigen. Maternal sensitization to the fetus may be of paternal 
origin, since the antibody present in the serum of Father Rh- can sensitize the 
Rh-mother, causing erythrocytic alloimmunization in the fetus during pregnancy 
(Nardo et al., 2009). This fetal alloimmunization that occurs during pregnancy is 
due to the fact that mothers with Rh negative do not present due anti-D 
immunoprophylaxis and are unaware of the partner's blood type A, B, O, causing 
future transfusion reactions in cases of hemotherapy (MORON et al., 2010). 
Possible extracellular variations of RhD protein occurring in the D antigen 
are induced by mutations of the epitopes causing partial loss of the genetic 
material which evolves into an anti-D alloantibody or a poor decrease in RhD 
antigen expression. This genetic mutation generates amino acid substitutions that 
interfere with the production of membrane and intracellular proteins, more 
specifically RHD proteins. We have a low expression of the D antigen protein, 
which makes it possible to categorize individuals with low or total Rh weak 
related to D (CASTILHOb et al., 2006). 
 
Kell system 
The Kell system consists of 20 antigens, the first antigen was K (Kell or K1), 
soon followed by the k antigen (Cellano or k2). These antigens are capable of 
sensitizing one individual to every 10 units of red blood cell concentrates 
transfused in a negative Kell patient. The antigens of the kell system are 
expressed in the red blood cell membrane and are also found in lymphatic tissues, 
skeletal muscles, lymphoid organs and so on. (HARMINGING p. 178, 2006). 
When the Kell system antigens are identified in the plasma of a newborn, it 
can progress to severe hemolytic anemia, as it causes an inhibitory effect on 
erythropoiesis (VAZa C.A.F, 2003). Some antibodies in this system do not 
activate the complement (plasma) even though they are IgG, but they can 
agglutinate Kell positive red cells in human serum. When they react at 37°C 
there is no complement activation (plasma), but they can cause extravascular 
hemolysis and also cause intravascular intravascular haemolysis in the blood 
vessels due to a weak reaction. Complementarily, hemolysis occurs in the vascular 
bed, leading to hepatic impairment leading to an increase in plasma hemoglobin 
and saturation of the hepatoglobin transport protein (HARMENING p. 179, 
2006). When Kell system antigens are present in donor blood and red blood cells 
are transfused in patients with negative Kell antigen, immediate, late hemolytic 
reactions and erythrocyte sensitizations occur (BORDIN, 2007). 
 
Duffy system 
Most of the antibodies in this system are identified in association with other 
antibodies activating the complement (plasma) because they are IgG. They can 
be classified as anti-Fya which is an antibody identified in complement (plasma) 
and is also an IgG, causing post-transfusion hemolytic reaction and DHPN rarely 
occurs. Anti-Fyb is difficult to find alone and is activated together with other 
Open  Science  Journal  
Review Article 	  
Open  Science  Journal  –  January  2017     	   6  
antibodies causing transfusion reactions (COVAS et al., 2007). These antibodies 
react on direct and indirect human antiglobulin tests, but may be masked with 
the use of enzymes (VAZb C.A.F., et al. 2001). 
In the transfusion practice, Fya and Fyb are considered the main antigens of 
the system. Fya antigen has a high frequency in Asian individuals, approximately 
100% of the population, has a frequency three times lower than anti-k. However, 
anti-Fyb is less frequent in the population than anti-Fya and is generally 
identified in association with other antibodies (COVAS et al., p. 148-149, 2007) 
The Duffy system has a biological function acting as a merozoite receptor for 
Plasmodium vivax, a parasite that causes malaria. In the studies of 
NOVARETTI et al., 2005 patients with erythrocytes Fy (a- b-) have a resistance 
in the membranes of the erythrocytes that blocks the invasion of malaria 
parasites. 
 
Kidd system 
This system is composed of less frequent antibodies classified as anti-Jka and 
anti-Jkb. Because they are IgG they react together with other antibodies and are 
identified in complement in the IgM or IgG phases in the plasma of the patient 
who received blood transfusion. The antigens of this system are classified as Jka 
and Jkb cause immediate and late hemolytic reactions and in some cases DHPN 
(COVAS p.156-157; 2007). 
Anti-Jka and anti-Jkb antibodies are not found in tissues, usually those 
antibodies are identified in the pre-transfusion searches associated with other 
antibodies. Anti-JKA has a higher frequency in individuals than anti-JKb, and 
can be identified in association with other antibodies in the IgG and IgM phase 
(COVAS et al., p. 157-158; 2007). 
 
Lewis system 
This system is related to the antibodies identified in the Rh system protein. 
It represents about 20% of the irregular antibodies identified in individuals who 
have the Lea and Leb antibodies; Is often not derived from a history of 
alloimmunization (COVAS et al., p. 153-154, 2007). It is found only in 
individuals whose red blood cells are Le (a- b-); Especially in women in the 
reproduction period. There is still no plausible explanation for this fact 
(HARMINGING, p. 151-153, 2006). 
Most antibodies to the anti-Lewis system are IgM and react at a temperature 
of 30°C and remain activated in the complement. Due to the fact that they react 
below the temperature of 30ºC, they are considered as natural antibodies 
(HARMENING p. 152, 2006). 
Individuals who have antibodies to the Lewis system do not have 
alloimmunization information, but already those that have antibodies can raise 
the titration of existing antibodies, resulting in the production of antibodies in 
individuals who do not possess the Lewis system. Antigens from the Lewis system 
are classified as anti-Lea and anti-Leb antibodies that are poorly potent because 
they are IgM and are rarely IgG, but may cause in vitro hemolysis; These 
antigens are common in individuals of blood groups A and B (COVAS et al., 143, 
2007). 
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Insignifying antibodies 
 
MNSs system 
The antigens of this system are naturally occurring and are considered 
polyphomorphic because of the antigenic association to glycophorins A and B 
that are located in the erythrocyte membrane. These glycophorins express 
autoantibody activities of the MNSs system, but not all the occurrence of these 
autoantibodies is related to this system. Glycophorin A expresses anti-M or anti-
N antigen activities, whereas anti-N and anti-S anti-s antigens are expressed by 
glycophorin B (HARMENING p.166; 2006). 
Antigens from this system are identified by the screening of low and high 
frequency antibodies in cases of unexpected incompatible cross reaction. They 
have clinical significance when they react to IgG or IgM in the hot or cold phases 
(HARMENING p.170; 2006). 
 
 
Human antiglobulin tests 
 
The human antiglobulin (HAG) test is done by two direct and indirect methods. 
 
Direct method 
It is a widely used method for the detection of autoimmune hemolytic 
anemias and in hemolytic transfusion reactions and hemolytic diseases of the 
newborn. The direct method is simple and detects RBC sensitization in vivo in 
the IgG phase or components it can activate. This technique can be performed in 
a tube or gel. In the tube method, the serum of human antiglobulin is added to 
the red cells under test, previously washed with saline. By the gel method, it is 
not necessary to wash the red cells, only added to the red cells diluted in the 
HAG-containing gel (NETO et al. 2013). The test identifies IgG-phase sensitized 
red blood cells or antibodies activated by induction of drugs such as penicillin, 
methyldopa, quinine, phenacetin and others that may cause reactivity in this 
test. There are also reports that some illnesses related to infections, immune 
disorders, cardiolipin, acquired immunodeficiency syndrome, malignant diseases, 
solid tumors, hematological diseases (macrocytic or microcytic anemias), early 
stage breast cancer can trigger positivity to the membranes of the red blood cells, 
Causing hemolytic reactions observed in the human antiglobulin test (PLETSCH 
et al., 2013). 
To understand the positivity of the direct antiglobulin test, it is necessary to 
know the clinical situation of the patient, such as type of drug therapy, 
transfusion history, age among others (PLETSCH et al., 2013). For the same 
purpose there is also the quick direct manual test of low cost TPD - 
Hexadimetrine bromide (Polybrene®) used for the detection of autoimmune 
hemolytic anemia. It is based on a technique where blood is preserved in test 
tubes containing sodium citrate, which avoids the aggregation of red cells by IgG 
(KURODA et al., 1998). 
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Indirect method 
It is also used to detect antibodies present in plasma or serum. These 
antibodies are observed in the tests in red cells with the use of commercial 
reagents tested in the serum or plasma of the patient or blood donor, observing 
the sensitization of the receptor with the red blood cells of the donor. The 
indirect method is known as Coombs Indirect method, detects the presence of 
antibodies in serum or plasma. The reagent red cells used in this method are 
marketed cells that are used to identify which cell occurs in the erythrocyte 
positivity that are referred to as a screening or screening panel (NETO et al., 
2013). 
The Antiglobulin Test is used to: 
• Erythrocyte Phenotyping - Used to detect the antigens present in serum 
or plasma, identifying for example: anti-D with weak D determination; 
determine the anti-Kell antigen; and others (NETO et al., 2013). 
• Irregular antibody screening - Used to detect antibodies present in serum 
or plasma and monitor negative Rh (D) in pregnant women (NETO et al. 
2013). 
• Cross-test - To detect agglutination caused by antibodies present in 
serum or plasma of the recipient, when tested with donor red blood cells 
(NETO et al. 2013). 
• Identification of irregular antibodies - To detect the types of antibodies 
after an agglutination observed in the pregnant sample, patients who 
undergo blood transfusion (NETO et al. 2013). 
 
 
Materials and methods 
 
This study was carried out through a bibliographical research based on a 
broad reading in scientific articles published in the period from 2000 to 2014 
available on the following websites: SciELO - Scientific Electronic Library Online, 
LILLACS - Latin American and Caribbean Literature on Health Sciences, 
PubMed - US National Librany of Medicine and BIREME - Regional Library of 
Medicine. 
The following inclusion criteria were used: articles published in Portuguese, 
English and Spanish. As exclusion criterion: review articles that did not directly 
address the issue of irregular antibodies and blood transfusion. 
The descriptors used were blood transfusion, antibodies to the Rh and Kell 
system, autoimmune hemolytic diseases, sickle cell anemia, thalassemias, 
sensitization by anti-D antibodies, immunoglobulin D and hemolytic anemia. 
From these descriptors the articles were selected covering blood transfusions and 
the results of the identification of irregular antibodies in patients who underwent 
blood transfusion. 
 
 
Results and discussion 
 
There were 51 articles in alternate sites: 43 in Scielo, 2 BIREME, 1 LILLACS 
and 5 in PubMed. Only 22 articles met the inclusion criteria proposed for the 
Open  Science  Journal  
Review Article 	  
Open  Science  Journal  –  January  2017     	   9  
study. From this total of articles selected, they were distributed in several 
categories of descriptive, qualitative or quantitative studies. Of these articles 
analyzed for study, they were published in the period from 2000 to 2014. 
VIEIRA et al. (2009) reported that blood group genotyping is successfully 
performed in transfusion therapies. The molecular techniques PCR and PCR-
RFLP is used successfully in large blood banks in the results in that the 
serological techniques are ineffective for conclusion of the results. The extended 
use of these techniques in patients entering a blood transfusion program greatly 
reduces erythrocyte sensitization. 
Additionally, PERON et al. (2013) concluded that polytransferred patients 
are more sensitized due to the amount of transfused red blood cells. The use of 
phenotyped red cells for the antigens of the Rh, Kell, Duffy, Kidd and MNSs 
system is fundamental. Although patients who already exhibit irregular 
antibodies may be more likely to acquire new erythrocyte antibodies. 
STINGHEN et al. (2013) found that phenotypes should be performed on all 
blood transfusions even if antibodies were not identified in alloimmunized 
patients. Di antibody was shown to be relevant and meaningful in their studies 
because it can be the cause of transfusion hemolytic diseases in neonatal. He also 
confirmed in his conclusions that the greater the number of blood transfusions 
performed, the patients are exposed to unusual antibodies, leading to the 
development of erythrocyte antibodies. 
In a complementary manner, SOUZA et al. (2012) reported that pre-
transfusion phenotypes should be widely used in transfused red blood cells in 
patients in clinical, surgical and acute disease states. And these therapeutic 
transfusions must be phenotyped with HC compatible with the Rh and Kell 
system. 
RUAS et al. (2013) observed that in the majority of transfused patients 
where phenotyping was performed there was a decrease in alomimunization. 
PINHEIROS and collaborators (2013) reported the importance of blood group 
knowledge and blood donation. 
MEDEIROS et al. (2010) reported that in blood donors from the 
Hemotherapy Service of the municipality of Primavera do Leste, several different 
phenotypes were found between blood groups O, A, B and AB. They found that 
the most frequent phenotype was of the O group and the less frequent AB. He 
also noted the predominance of class O, Rh+ and A, Rh+, but the lowest 
prevalence was the class AB, Rh-. 
NARDOZZA et al. (2009) concluded that all Rh negative pregnant women 
should determine the blood group. They should be informed of the possibility of 
blood incompatibility related to their partners. If they are positive or unknown, 
the pregnant woman will perform an indirect coombs if she remains negative, it is 
recommended that intra-D anti-D prophylaxis be performed at the 28th week and 
the first 72 hours after delivery or up to 28 days being reapplied every 12 weeks 
in pregnant women. Although atypical gestational events such as molar or ectopic 
gestation, genital bleeding and abdominal trauma in pregnancy, chorionic villus 
sampling, amniocentesis, funiculocenesis, external cephalic version or fetal death, 
intramuscular anti-D is recommended for the first 72 hours After the event. 
Attenuated virus vaccines should only be applied six months after anti-D 
administration. 
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COSTA et al. (2000) observed that the identification of the Rh, Kell, Duffy 
and Kidd phenotypes in conjunction with the A, B, O system prevents 
erythrocyte sensitization and distinguishes antibodies in patients with B 
thalassemia. Although it is costly, the RFLP PCR method is used in detriment of 
the phenotyping of these patients. 
CASTILHO et al. (2006) reported that poor RhD antigen is not always 
identified in serological and immunohematological methods. In this case 
molecular techniques are used to distinguish weak RhD types. The identification 
of weak RhD is performed by the direct human anti-globulin test at room 
temperature with anti-D IgM and the anti-D human IgG antiglobulin test. 
However, in this study the anti-D IgM test revealed no partial Dfraco antigens 
and no density-decreasing antigens used in the routine of the patients. Thus, anti-
D IgG was shown to be effective in identifying total Dfraco in partial Dfraco 
aggregations, making it a routine blood donor test. 
SILVA et al. (2011) reported the importance of phenotyping for Rh and Kell 
system antigens due to the immunogenicity of these antibodies causing 
associations with other types of antibodies. Rh negative with donors should be 
analyzed when presenting antigens E, C or K following the protocols of the 
legislation. This idea is reinforced because antibodies can cause significant DHPN 
and sensitize other phenotypes. 
KURODA et al (1998) concluded that the direct manual test Polybrene® 
(TPD) has high action on the TCD. The TPD method is fast and inexpensive, 
making it a helper method in the diagnosis of autoimmune hemolytic anemia 
(AIHA).  
NETO et al (2013) reported that the antiglobulin test is effective in the 
diagnosis of autoimmune anemia which may be caused by changes in hemoglobin 
in red cell structure or drug-induced anemias. 
PLECTSH and colleagues (2013) found that human direct antiglobulin test was 
applied to blood donors in direct Coombs test method. When he identified the 
positive hemolytic disease; the application of the test was performed in all the 
packed red blood cells to be transfused, establishing a protocol, thus avoiding 
future problems related to the positive TAD. 
MORON et al. (2010) pointed out that the molecular elucidation of the Rh 
system determines the variants related to this system population. Molecular 
biology is being used to identify Rh negative phenotypes in pregnant patients 
with enlargement of the genotypes and the prevention of Rh alloimmunization. 
The primacy of the molecular method avoids the anti-D immunoprophylaxis in 
RhD negative pregnant women and the variations found in the RhD type Dfraco 
full and partial Dfraco. 
SANTOS et al. (2011) conclude that the superiority of alloimmunization in 
patients with sickle cell disease (SS) was relevant because of the identified 
antibodies are systems of blood groups Rh and Kell. Thus, the importance of 
extending erythrocyte phenotyping blood donors and patients to prevent the 
reduction of alloimmunization risk. 
HIRTSCH and colleagues (2004) reported the importance of including the 
identification of antigen Dia (Diego) in research (RIA) in any population, because 
this antibody and very significant and cause awareness in pregnant women at 
delivery. 
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MIYADALINA 2000, found that still remains a serious problem 
alloimmunization related to Rh. This is due to failures in the use of prophylaxis 
of Rh alloimmunization in prenatal and postpartum; that prophylaxis should be 
applied as prevention erythrocyte sensitization in Rh negative women. 
Chamone and colleagues (2003) proposed the investigation of anti-U antibody 
when it is found in black and brown women the identification of high affinity 
antibodies. 
MORITZ et al. (2009) reported the characterization of granulocyte antigens. 
The molecular basis can be identified through the use of genotyping PCRSSP 
(single primer specific - polymerase chain reaction). However, due to shortage of 
reagents and testing kits of commercial antibodies neutrophils are few conducted 
restricting the specialized laboratories in granulocyte immunology; so not all cases 
of neutropenia immune are investigated. Due to advances in diagnostic 
technology it is believed that this will facilitate the prevention of future 
transfusion reactions and autoimmune diseases caused by neutrophils. 
DUARTE et al (2008) envisioned the technology of erythrocytes magnetized 
EM® Technology, a major innovation in imunohematológicos trials. The manual 
equipment used in Freelys®Nano name Workstation is an easy-handling 
equipment, economic and utilizes a small sample volume. In this equipment is 
made blood ratings ABO, RhD, PC, fenotipagens and RIA. In this method occur 
100% of methodological efficacy in pre-transfusion testing. However, the RIA and 
PC was made using an IgG antiglobulin 37 which allowed the identification of 
IgG antibodies in phase. The brazilian RDC no 153 of June 14, 2004 determines 
the detection of antibodies in 37 significant at the stage of HAG, but the 
equipment of EM®Techonology does not identify IgM antibodies. 
JUNIOR et al. (2004) reported that the application of molecular techniques 
PCR in conjunction with the hemagglutination in transfusion medicine, increases 
the safety of blood transfusions. About this genotyping technique not know if you 
can come and replace the hemagglutination future, but together has great 
potential value in transfusion and maternal and fetal safety. 
In the period 2012-2013 the Rh and Kell system antibodies are the most 
common in our results, these antibodies are acquired through incompatible 
transfusions HC without erythrocyte fenotipagens, causing the sensitization on 
the patient. This is due to antibody inducibility the immune response of the 
recipient. 
We observed significant incidence of major anti-E, anti-C, anti-K, anti-D, 
anti-Fy a, anti-Jk a and minor anti-F, anti-C, anti-S and anti- s. 
The presence of anti-D, can be a blood donor with Rh D antigen presenting a 
partial, not identified in the use of monoclonal anti-D antisera, allowing the 
production of anti-D. 
Patients who undergo blood transfusion due to decreased survival of red 
blood cells caused by the disease, leaving the patient vulnerable to develop 
erythrocytic alloantibodies. Thus the use of phenotyped red blood cells to the 
antigens of the Rh system, Kell, Duffy, Kidd and MNSs are essential to prevent 
the formation of new alloantibodies in alloimmunized patients. For these 
individuals already alloimmunized are more likely to produce irregular antibodies 
compared to individuals not sensitized. 
We note that the identification of irregular antibodies is more relevant in 
patients receiving blood transfusion. As irregular antibodies are in most clinical 
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significance increasing interest in research of irregular antibodies in future 
transfusions in patients with acute and chronic diseases, in cases of emergency 
care or in diseases such as hemolytic anemia and non-hemolytic. 
The main antibodies were agrupadamente independent of the patient's illness 
related to the number of blood transfusions performed, emergency and urgent, 
number of pregnancy and the occurrence of different gestational partners. 
Because not be performed phenotyping before blood transfusions occurs future 
consequences to the welfare of the patient in transfusion therapy. 
In this study we noted that the identified primary antibodies were anti-K, 
anti-E, anti-c, anti-D, anti-Fy a, anti-F, anti-C, anti-S, anti-Dihydroxy. In anti-D 
case was reported identification of this antibody in patients who had no history 
transfusion because of a treated primary sensitization. 
Analyzing the results and discussion, we observe methods used currently 
applied in the pre-transfusion research to prevent immediate or future transfusion 
reactions. Some authors cite the importance of phenotyping and genotyping prior 
blood transfusions, but not all hemotherapy units perform these tests without a 
prescription and because of the unwillingness of the test equipment and 
performed manually. Molecular biology has proved to be a breakthrough in the 
pre-transfusion research in the identification of antibodies to Rh systems, kel, 
Duffy, Kidd and MNSs, preventing future sensitization, but not all hemotherapy 
units can make use of the methods in PCR, due to high cost of the apparatus. 
Then apply the methods and gel tubes but is not as effective in solving the false 
positive results. 
Thus, the Brazilian Ministry of Health in conjunction with the RDC no 153 
reinforce the use of blood fenotipagens with negative red blood cell for individuals 
who have the positive antibodies. 
 
 
Conclusion 
 
This study demonstrated a significant frequency of irregular antibodies 
identified in patients who undergo blood transfusion. Most of these antibodies is 
of significance are the Rh, Kell, Duffy and Kidd and clinical insignificance are the 
MNSs system. The most common antibodies are Rh and Kell system. 
It was observed that the identified antibodies in pre-transfusion research occur 
greatly due to the awareness of patients linked to the number of transfusions and 
the association between the Rh antibodies and Kell may disappear after months 
remain in the body. 
Antibodies identified in association with other antibodies were anti-K, anti-E, 
anti-D, anti-C, anti-Fy a, anti-F, anti-C, anti-C, anti-S and anti-Dihydroxy. 
These antibodies goes unnoticed in research in pre-transfusion blood transfusion, 
causing immune hemolytic diseases or immediate / delayed or until the patient 
morbidity reactions. 
We conclude that the antibodies identified in transfused patients are relevant 
and worrying. Thus, applies the need for infusion concentrates phenotyped 
erythrocytes for the Rh antigens, Kell, Duffy, Kidd, MNSs and others, and 
carrying out the genotyping of blood groups for hemotherapeutic treatment with 
safety and quality for the patient. 
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